Anti-Programmed death-1 therapy in advanced hepatocellular carcinoma: A real-world experience.
Clinical case reports（2021）
Abstract
Nivolumab is an effective and safe treatment in HCC.
MoreTranslated text
Key words
clinical outcomes,hepatocellular carcinoma,nivolumab,survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined